File:Deferoxamine, deferiprone, and deferasirox mechanism of action in the management of iron overload.jpg

From Wikimedia Commons, the free media repository
Jump to navigation Jump to search

Captions

Captions

chelation therapy

Summary

[edit]
Description
English: Deferoxamine, deferiprone, and deferasirox mechanism of action in the management of iron overload. Deferoxamine binds to nontransferrin bound iron or to iron found in ferritin forming a molecule which is later excreted via the kidneys. Deferoxamine also promotes ferritin degradation in lysosomes. Deferiprone and deferasirox chelate cytosolic labile iron. Besides, deferasirox can increase the levels of hepcidin that results in the degradation of ferroportin. TFR, transferrin receptor.
Date
Source https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098311/
Author Entezari S, Haghi SM, Norouzkhani N, Sahebnazar B, Vosoughian F, Akbarzadeh D, Islampanah M, Naghsh N, Abbasalizadeh M, Deravi N.

Licensing

[edit]
w:en:Creative Commons
attribution
This file is licensed under the Creative Commons Attribution 4.0 International license.
You are free:
  • to share – to copy, distribute and transmit the work
  • to remix – to adapt the work
Under the following conditions:
  • attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

File history

Click on a date/time to view the file as it appeared at that time.

Date/TimeThumbnailDimensionsUserComment
current21:43, 6 May 2024Thumbnail for version as of 21:43, 6 May 2024590 × 456 (137 KB)Ozzie10aaaa (talk | contribs)Uploaded a work by Entezari S, Haghi SM, Norouzkhani N, Sahebnazar B, Vosoughian F, Akbarzadeh D, Islampanah M, Naghsh N, Abbasalizadeh M, Deravi N. from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098311/ with UploadWizard

There are no pages that use this file.

Metadata